Results 11 to 20 of about 101,846 (359)

Apremilast

open access: yesTurkderm Turkish Archives of Dermatology and Venereology, 2022
Apremilast is an orally used small-molecule inhibitor of phosphodiesterase-4. It has been approved for the treatment of adult patients with psoriatic arthritis and moderate to severe plaque psoriasis.
Nihal Kundakçı
doaj   +1 more source

Effect of a three-piece inflatable penile prosthesis combined with a phosphodiesterase-5 inhibitor on erectile dysfunction

open access: yesJournal of International Medical Research, 2021
Objective To investigate the therapeutic effect of implanting a three-piece inflatable penile prosthesis (IPP) combined with the phosphodiesterase-5 inhibitor sildenafil in severe erectile dysfunction (ED) patients.
Jian Wang   +6 more
doaj   +1 more source

Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA. [PDF]

open access: yesPLoS ONE, 2010
The purpose of the present study was to investigate whether cilostazol, a phosphodiesterase-III inhibitor and antiplatelet drug, would prevent tPA-associated hemorrhagic transformation.
Mitsunori Ishiguro   +10 more
doaj   +1 more source

Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease. [PDF]

open access: yesPLoS ONE, 2011
BACKGROUND: Phosphodiesterase 7 plays a major role in down-regulation of protein kinase A activity by hydrolyzing cAMP in many cell types. This cyclic nucleotide plays a key role in signal transduction in a wide variety of cellular responses.
Jose A Morales-Garcia   +7 more
doaj   +1 more source

Effects and mechanisms of action of sildenafil citrate in human chorionic arteries

open access: yesReproductive Biology and Endocrinology, 2009
Objectives Sildenafil citrate, a specific phosphodiesterase-5 inhibitor, is increasingly used for pulmonary hypertension in pregnancy. Sildenafil is also emerging as a potential candidate for the treatment of intra-uterine growth retardation and for ...
Lynch Tadhg   +7 more
doaj   +1 more source

Phosphodiesterase Inhibitor-Based Vasodilation Improves Oxygen Delivery and Clinical Outcomes Following Stage 1 Palliation. [PDF]

open access: yesJ Am Heart Assoc, 2016
BackgroundSystemic vasodilation using α‐receptor blockade has been shown to decrease the incidence of postoperative cardiac arrest following stage 1 palliation (S1P), primarily when utilizing the modified Blalock‐Taussig shunt.
Mills KI   +13 more
europepmc   +2 more sources

Hemorrhagic Cholecystitis in an Elderly Patient Taking Aspirin and Cilostazol

open access: yesCase Reports in Gastroenterology, 2008
Hemorrhage is a rare complication of acute cholecystitis. Patients who develop this complication often are receiving anticoagulation therapy or have a pathologic coagulopathy.
David S. Morris   +2 more
doaj   +1 more source

Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus

open access: yesNature Communications, 2023
Pemphigus vulgaris is a life-threatening blistering skin disease caused by autoantibodies which destabilize cell adhesion of keratinocytes. The phosphodiesterase 4 inhibitor apremilast prevents skin blistering by stabilizing the keratin filament ...
Anna M. Sigmund   +19 more
doaj   +1 more source

Effects of KF19514, a Phosphodiesterase 4 and 1 Inhibitor, on Bronchial Inflammation and Remodeling in a Murine Model of Chronic Asthma

open access: yesAllergology International, 2009
Background: Phosphodiesterase 4 selective inhibitor may prevent airway inflammation and remodeling. Objective: The aim of this study was to investigate the effects of KF19514, a phosphodiesterase 4 and 1 dual inhibitor, on chronic airway inflammation and
Toshiyuki Kita   +5 more
doaj   +1 more source

Research of cGMP- and cAMP-dependent intracellular signaling systems in the insulin-mediated regulation of platelets aggregation activity in patients with heart failure and metabolic disturbances

open access: yesБюллетень сибирской медицины, 2012
Data of the study of cGMP- and cAMP-dependent intracellular signaling systems in the insulin-mediated regulation of the platelet aggregation activity in 25 patients with DM2 and heart failure are presented.
O. N. Ogurkova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy